Back to ACAD
COMMONWEALTH EQUITY SERVICES, LLC → ACAD
COMMONWEALTH EQUITY SERVICES, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
8
Latest value
$4.8M
Q3 2026
Peak value
$4.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $393K |
| Q4 2025 | $4.5M |
| Q1 2026 | $335K |
| Q1 2026 | $4.5M |
| Q2 2026 | $367K |
| Q2 2026 | $4.7M |
| Q3 2026 | $292K |
| Q3 2026 | $4.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.8M | 27.4K | — | — |
| Q3 2026 | $292K | 14.5K | — | — |
| Q2 2026 | $4.7M | 26.6K | — | — |
| Q2 2026 | $367K | 14.5K | — | — |
| Q1 2026 | $4.5M | 27.2K | — | — |
| Q1 2026 | $335K | 15.0K | — | — |
| Q4 2025 | $4.5M | 25.1K | — | — |
| Q4 2025 | $393K | 14.7K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M